The newest indications for monoclonal antibodies are as treatment for homozygous familial hypercholesterolemia, advanced triple-negative breast cancer, advanced urothelial cancer, relapsed or refractory large B-cell lymphoma, and non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.NAJ.0000790620.26025.1f | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!